Form 4: Director Myriam Curet Receives RSU Grant at Inspire Medical
Insider Transaction Report
Director Myriam Curet was granted 3,562 restricted stock units in Inspire Medical Systems, Inc. as part of an equity award.
Summary
- Director Myriam Curet acquired 3,562 restricted stock units (RSUs) on April 30, 2026.
- Each RSU represents a contingent right to receive one share of common stock.
- The total beneficial ownership for the director following this transaction is 6,927 shares of common stock.
- The grant was issued at a price of $0 per share.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no significant market sentiment.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified.
Risks
- Vesting is subject to the director's continued service with the issuer.
- Vesting may be accelerated in the event of a Change of Control as defined in the 2018 Incentive Award Plan.
Future Outlook
The RSUs are scheduled to vest on the first anniversary of the grant date (April 30, 2027) or immediately prior to a Change of Control, provided the director remains in service.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.
Comparison to Industry Standards
- The use of RSUs for director compensation is consistent with standard practices for mid-cap medical device companies.
- Vesting schedules tied to annual service or change-of-control events align with typical executive and director compensation structures.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of 3,562 RSUs to Director Myriam Curet under the 2018 Incentive Award Plan. | 04/30/2026 | Standard alignment of director incentives with shareholder interests. |
Stakeholder Impact
- Shareholders: Minor dilution impact, though standard for director compensation packages.
Next Steps
- Vesting of the 3,562 RSUs on April 30, 2027, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 04/30/2026 | Date of the RSU grant transaction. |
| 05/04/2026 | Date the Form 4 was signed and filed. |
Keywords
Inspire Medical Systems, INSP, Form 4, Insider Trading, Restricted Stock Units, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.